Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2H-naphtho[1,2-b][1,4]diazepine-2,4(3H)-diones as P2X4 Receptor Antagonists.

Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2H-naphtho[1,2-b][1,4]diazepine-2,4(3H)-diones as P2X4 Receptor Antagonists.
复制标题

DOI:
10.1021/acs.jmedchem.2c01197
复制
发表时间:
2022-10-27
影响因子:
7.3
通讯作者:
Jacobson KA
Jacobson KA
中科院分区:
医学1区
文献类型:
--
作者:
Toti KS;Verma R;McGonnigle MJ;Gamiotea Turro D;Wen Z;Lewicki SA;Liang BT;Jacobson KA

文献摘要

参考文献

相似文献

我们分析了已知拮抗剂1,5-二氢- 2h -萘[1,2-b][1,4]二氮平-2,4(3H)-二酮的P2X4受体结构-活性关系。经过对合成路线的广泛修改,4-吡啶基21u (MRS4719)和6-甲基22c (MRS4596)类似物对人(h) P2X4R最有效(IC50分别为0.503和1.38 μM),对hP2X1R, hP2X2/3R, hP2X3R有选择性)。因此,萘6-而非7-位可被取代,n -苯基环偶氮扫描鉴定出21u的活性比5高3倍。化合物21u和22c对缺血性脑卒中小鼠模型具有神经保护和学习记忆增强作用,其效价为21u和22c。21u分别在脑卒中后3天和35天剂量依赖性地减少梗死体积和脑萎缩。与临床意义相关的是,21u还减少了原代人单核细胞源性巨噬细胞中atp诱导的[Ca2+]i内流。这项研究表明P2X4R拮抗剂治疗缺血性卒中的转化潜力,包括老年人群。
We analyzed the P2X4 receptor structure–activity relationship of a known antagonist 5, a 1,5-dihydro-2H-naphtho[1,2-b][1,4]diazepine-2,4(3H)-dione. Following extensive modification of the reported synthetic route, 4-pyridyl 21u (MRS4719) and 6-methyl 22c (MRS4596) analogues were most potent at human (h) P2X4R (IC50 0.503 and 1.38 μM, respectively, and selective versus hP2X1R, hP2X2/3R, hP2X3R). Thus, the naphthalene 6-, but not 7-position was amenable to substitution, and an N-phenyl ring aza-scan identified 21u with 3-fold higher activity than 5. Compounds 21u and 22c showed neuroprotective and learning- and memory-enhancing activities in a mouse middle cerebral artery occlusion (MCAO) model of ischemic stroke, with potency of 21u > 22c. 21u dose-dependently reduced infarct volume and reduced brain atrophy at 3 and 35 days post-stroke, respectively. Relevant to clinical implication, 21u also reduced ATP-induced [Ca2+]i influx in primary human monocyte-derived macrophages. This study indicates the translational potential of P2X4R antagonists for treating ischemic stroke, including in aging populations.
乙醇差异调节BV2小胶质细胞中的P2X4和P2X7受体活性和功能。
DOI: 10.1016/j.neuropharm.2017.09.030
发表时间: 2018-01
期刊: Neuropharmacology
影响因子: 4.7
作者:
Asatryan L;Ostrovskaya O;Lieu D;Davies DL
通讯作者: Davies DL
DOI: 10.1016/j.ynpai.2017.04.001
发表时间: 2017-01-01
期刊: Neurobiology of pain (Cambridge, Mass.)
影响因子: --
作者:
Malcangio, Marzia
通讯作者: Malcangio, Marzia
DOI: 10.1038/s41380-019-0641-8
发表时间: 2020-01-08
影响因子: 11
作者:
Bertin, Eleonore;Deluc, Thomas;Boue-Grabot, Eric
通讯作者: Boue-Grabot, Eric
DOI: 10.1016/j.coph.2019.02.011
发表时间: 2019-08-01
影响因子: 4
作者:
Antonioli, Luca;Blandizzi, Corrado;Hasko, Gyorgy
通讯作者: Hasko, Gyorgy
DOI: 10.1007/s11255-018-1948-0
发表时间: 2018-09
影响因子: 2
作者:
Dunton CL;Purves JT;Hughes FM Jr;Jin H;Nagatomi J
通讯作者: Nagatomi J